Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Aug 04, 2017, 07:58 ET TrialScope lance son nouvel outil SaaS de gestion de divulgation d'essai : Core Disclosure

La société propose une solution permettant la réutilisation et l'alignement des données de divulgation sur l'ensemble des registres mondiaux...


Aug 04, 2017, 07:30 ET First Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting

Accuray Incorporated (NASDAQ: ARAY) announced today that the first studies validating the benefits of the leading-edge Radixact™ System were...


Aug 04, 2017, 06:45 ET Lilly Announces Positive Results for Second Phase 3 Study of Lasmiditan for the Acute Treatment of Migraine

Eli Lilly and Company (NYSE: LLY) announced today that lasmiditan, an investigational, oral, first-in-class molecule for the acute treatment of...


Aug 03, 2017, 14:25 ET University of Maryland Medicine Establishes Nation's First Center for Cardiac Xenotransplantation Research With $24 Million Grant and Addition of Top Transplant Surgeon-Scientists

Stephen Bartlett, MD, chair of the Department of Surgery at the University of Maryland School of Medicine, and UM SOM Dean E. Albert Reece, MD, PhD,...


Aug 03, 2017, 13:30 ET Avelas Biosciences Doses First Patient in Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment,...


Aug 03, 2017, 11:46 ET Feinstein Institute study finds robotic ankle rehabilitation helps post stroke recovery

A study published in NeuroRehabilitation by Feinstein Institute for Medical Research scientist Bruce T. Volpe, MD and Johanna L. Chang found that...


Aug 03, 2017, 11:32 ET TrialScope Launches New SaaS Clinical Trial Disclosure Management Tool: Core Disclosure

TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced the launch of its newest solution, Core...


Aug 03, 2017, 09:00 ET Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis

Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its major investment...


Aug 03, 2017, 09:00 ET DiscoverX and the SGC Announce Major Milestone in Development of Kinase Chemogenomic Set

DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, in collaboration with...


Aug 03, 2017, 09:00 ET Chondrial Announces FDA Orphan Drug Designation for CTI-1601, a Novel Investigational Technology for the Treatment of Friedreich's Ataxia

Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that the...


Aug 03, 2017, 08:08 ET Linguamatics and RealHealthData Partner to Extract Real World Evidence from Patient Narratives

Natural Language Processing (NLP) text analytics provider Linguamatics, and RealHealthData, a narrative medical records database provider, today...


Aug 03, 2017, 08:00 ET Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary...


Aug 03, 2017, 07:00 ET VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers

VM BioPharma, the United States division of ViroMed Co., Ltd. in Seoul, Korea (KOSDAQ: 084990), today announced the first patient was dosed in the...


Aug 03, 2017, 07:00 ET Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary...


Aug 03, 2017, 06:30 ET Regeneron Reports Second Quarter 2017 Financial and Operating Results

- Second quarter 2017 EYLEA® (aflibercept) Injection U.S. net sales increased 11% to $919 million versus second quarter 2016 -...


Aug 02, 2017, 17:05 ET MiMedx Reports Exceptional Results in Phase 2B Clinical Trial on the Use of AmnioFix® Injectable in the Treatment of Plantar Fasciitis

MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics...


Aug 02, 2017, 16:01 ET BioMarin Announces Plans to Progress Both the 6e13vg/kg and 4e13 vg/kg Doses of BMN 270, its Investigational Gene Therapy for Hemophilia A, into Phase 3 Studies

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that it will expand its development plan for BMN 270, its investigational gene therapy...


Aug 02, 2017, 15:28 ET ImPACT Applications Increases Its Support of Concussion Studies at Harvard Medical School and Spaulding Rehabilitation Hospital

ImPACT Applications, Inc., developer of FDA-approved ImPACT®, FDA-approved ImPACT Pediatric®, FDA-approved ImPACT Quick Test™, and the ImPACT...


Aug 02, 2017, 15:10 ET Enzychem Lifesciences's investigational new drug application (IND) for chemoradiation induced oral mucositis had been granted by the FDA

The U.S. Food and Drug Administration (FDA) has granted Enzychem Lifesciences, Corp. (KONEX:183490), the largest life sciences company in South...


Most Viewed